Avanzanite Bioscience
PrivateLast Round
Series A
Nov 18, 2025
Total Funding Raised
$37.1M
Momentum Score
25 /100
Company Overview
Avanzanite Bioscience is a specialty pharmaceutical company that offers a commercialization platform for biopharmaceutical partners to launch and distribute medicines for rare diseases across Europe.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avanzanite Bioscience Comps
Public and private peers based on sector, stage, and business model.
Avanzanite Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 18, 2025 |
Key People
Founding team and executive leadership
Avanzanite Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MVM Life Science Partners LLP | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Grew 17% QoQ, from 64 to 75 employees.
- Mar 24, 2026
Operations expanded in France with a new General Manager appointed.
Avanzanite Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avanzanite Bioscience's valuation, stock price, and market status.
